Mr. Peter Copetti reports

POET TECHNOLOGIES ANNOUNCES THE APPOINTMENT OF TWO NEW DIRECTORS

Poet Technologies Inc. has appointed two new directors to fill vacancies, the most recent of which was created by the resignation of the company's distinguished director, Adam Chowaniec, as a result of the illness leading to his recently announced passing.

Peter Copetti, executive co-chairman and interim chief executive officer, stated, "Adam's loss left a very deep gap to fill, however, the corporate governance and nominating committee has been engaged in an extensive search to find suitable candidates to fill the role of permanent CEO and supporting executive staff and directors." John O'Donnell, the chairman of the CGNC, added, "The search has provided a short list of extremely capable and impressive candidates." Final decisions are not expected to be made until May with respect to the top executive roles, however the process has produced, to date, two very exceptional new directors with the semiconductor industry experience and relationships to help propel the company through its lab-to-fab transition.

Subject to all necessary regulatory approvals, the board has approved the following appointments.

Todd A. DeBonis is a veteran semiconductor executive with over 27 years of expertise in sales, marketing and corporate development. For the last decade, Mr. DeBonis was the vice-president of global sales and strategic development at TriQuint Semiconductor. During his tenure TriQuint experienced dramatic growth and recognition in the industry as the technology leader in RF solutions. Mr. DeBonis played an integral part in the recent merger with RFMD and subsequent creation of Qorvo Inc.

Mr. DeBonis previously held the position of vice-president, worldwide sales and marketing, at Centillium Communications. Mr. DeBonis also served as the vice-president, worldwide sales, for Ishoni Networks and vice-president, sales and marketing, for the communications division of Infineon Technologies North America. Mr. DeBonis has a BS degree in electrical engineering from the University of Nevada.

David E. Lazovsky is the founder of Intermolecular and served as the company's president and chief executive officer, and as a member of the board of directors, from September, 2004, to October, 2014. Mr. Lazovsky has an in-depth knowledge of the semiconductor industry, technology and markets. Mr. Lazovsky raised significant amounts of venture capital and other strategic private investments in Intermolecular's initial public offering. Prior to founding Intermolecular, Mr. Lazovsky held several senior management positions at Applied Materials. From 1996 through August, 2004, Mr. Lazovsky held management positions in the metal deposition and thin films product business group where he was responsible for managing more than $1-billion in Applied Materials' semiconductor manufacturing equipment business. From 2003 until 2004, Mr. Lazovsky managed key strategic accounts in business management where he worked closely with leading integrated circuit manufacturers to ensure Applied Materials was developing and providing cutting-edge technology solutions. From 2002 until 2003, Mr. Lazovsky served as the technology program manager for the Endura 2 platform, Applied Materials' flagship 300-millimetre metal deposition platform. From 2000 until 2002, Mr. Lazovsky was based in Grenoble, France, and served as director of business management for the European region in the metal deposition product business group. Previously, Mr. Lazovsky served as a business manager from 1997 to 2000, account product manager from 1995 to 1997.

Mr. Lazovsky holds a BS in mechanical engineering from Ohio University and, as of March 31, 2014, held 41 pending or issued U.S. patents.

Both Mr. Lazovsky and Mr. DeBonis are residents and industry players in the Silicon Valley. The company expects they will play a key role in helping the company position itself in this critical heart of the semiconductor ecosphere which is an important part of the focus of the company's future development plans.

Option grant

The board approved the grant of 250,000 stock options to each of Mr. Lazovsky and Mr. DeBonis, pursuant to the company's stock option plan. Pursuant to TSX Venture Exchange policies, and based on market price, the exercise price of the options was set at $1.99 per share and expire on April 8, 2020. The options will vest and be exercisable on the basis of 25 per cent six months after the date of issue and 25 per cent every six months thereafter.

We seek Safe Harbor.